TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial,  Studying the Delivery of SD-101 via Pressure-Enabled Drug Delivery in  Adults with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studying the Delivery of SD-101 via Pressure-Enabled Drug Delivery in Adults with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

News & Events News TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studying the Delivery of SD-101 via Pressure-Enabled Drug Delivery in Adults with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma DENVER and CHICAGO, May 10, 2022...